Jaid, Baby Boy .
HRN: 28-16-51 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
AMPICILLIN 250MG (VIAL)
12/01/2025
12/08/2025
IV
125 Mg
Q12hrs
MAS
Checking Initial Appropriateness
12/01/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/01/2025
12/08/2025
IV
37.5 Mg
Q24hrs
MAS
Checking Initial Appropriateness
12/01/2025
CEFOTAXIME 500MG (VIAL)
12/01/2025
12/08/2025
IV
125 Mg
Q12hrs
MAS
Checking Initial Appropriateness
12/01/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/01/2025
12/08/2025
IV
12.5 Mg
Q24hrs
MAS
Checking Initial Appropriateness